Rezdiffra patient using laptop
Rezdiffra patient using laptop

Enroll in the Rezdiffra Copay Savings Program. 

MADRIGAL PATIENT SUPPORT

Success!

You have been successfully enrolled in the Rezdiffra Copay Program.

Save on Rezdiffra.

Copay card

Not an actual card.

Eligible commercially insured patients may pay as little as $0 a month* with the Rezdiffra Savings Card.

*

Eligibility rules apply. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. For program terms, conditions, and eligibility criteria, see below.

Let’s get you enrolled.

Fill out this form to enroll in the copay program and capture the secure authorization needed for program support.

Eligibility

*Indicates a required field.

Patient information

*Indicates a required field.

*Rezdiffra Copay Program Consent

Madrigal Text Consent

Prescriber Information

*Indicates a required field.

Pharmacy Information

Provide authorization for assistance

*Indicates a required field.

To complete your enrollment in the Copay Savings Program, we’ll need your consent to participate in Madrigal Patient Support by signing the authorization form below. 

Madrigal Patient Support is provided at no cost and offers eligible patients:

• Help identifying financial assistance options 
• Support getting started and throughout treatment 
• Education and tips from Nurse Navigators 

Please review the information below and sign the form to continue.

Please print or write down the information on the card below. You will need to provide this information to the pharmacy that will be dispensing Rezdiffra. 

We’re Sorry!

Unfortunately, you are not eligible to participate in this program.

There may be other financial assistance programs available to you. If you need more information or want to discuss eligibility, please contact Madrigal Patient Support at 1-877-219-7770, 8AM - 8PM ET, Monday through Friday.

We’re Sorry!

We're having trouble processing your request.

Please contact the help desk at

ELIGIBILITY

  • Patient must have commercial insurance and the insurance does not cover the full cost of the prescription
  • Patients who are enrolled in a state or federally funded prescription insurance program are not eligible for this offer. This includes patients enrolled in Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DOD) programs, or TriCare
  • Not valid to cash-paying patients
  • Must reside in the US or US territory
  • Must be 18 years of age or older

TERMS OF USE

  • Eligible commercially insured patients with a valid prescription may pay as little as [$0] per month. Patient out-of-pocket expense may vary. Patients is responsible for applicable taxes, if any
  • The Rezdiffra Copay Program may have a monthly and annual cap which will be determined by the program sponsor and is subject to change at any time
  • Enrollment in the Rezdiffra Copay Program is valid for 12 months
  • Patient has a valid prescription for Rezdiffra
  • Other restrictions may apply. Patient is responsible for applicable taxes, if any
  • Nontransferable, limited to one per person, cannot be combined with any other offer
  • Patients, pharmacists, and prescribers cannot seek reimbursement from health insurance or any third party for any part of the benefit received by the patient through this offer
  • Madrigal reserves the right to rescind, revoke, or amend this offer, eligibility, and terms of use at any time without notice
  • This offer is not conditioned on any past, present, or future purchase, including refills
  • This offer is not health insurance
  • Certain information pertaining to your use of the Rezdiffra Copay Program will be shared with Madrigal Pharmaceuticals, the sponsor of the Rezdiffra Copay Program. The information disclosed will include the date the prescription is filled, the number of pills or product dispensed by the pharmacists, and the amount of your copay that will be paid for by using this Rezdiffra Copay Program. For more information, please see the Madrigal Privacy Policy at www.madrigalpharma.com
  • BY REDEEMING THIS OFFER, YOU AND YOUR PHARMACIST UNDERSTAND AND AGREE TO COMPLY WITH THESE ELIGIBILITY REQUIREMENTS AND TERMS OF USE

Important Safety Information and Indication

Expand Collapse

Before you take Rezdiffra, tell your healthcare provider about all of your medical conditions, including if you:

  • have any liver problems other than MASH.
  • have gallbladder problems or have been told you have gallbladder problems, including gallstones.
  • are pregnant or plan to become pregnant. It is not known if Rezdiffra will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if Rezdiffra passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take Rezdiffra.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

  • Rezdiffra and other medicines may affect each other, causing side effects. Rezdiffra may affect the way other medicines work, and other medicines may affect how Rezdiffra works.
  • Especially tell your healthcare provider if you take medicines that contain gemfibrozil to help lower your triglycerides, or cyclosporine to suppress your immune system, because Rezdiffra is not recommended in patients taking these medicines.
  • Tell your healthcare provider if you are taking medicines such as clopidogrel to thin your blood or statin medicines to help lower your cholesterol.
  • Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

What are the possible side effects of Rezdiffra?

Rezdiffra may cause serious side effects, including:

  • liver injury (hepatotoxicity). Stop taking Rezdiffra and call your healthcare provider right away if you develop the following signs or symptoms of hepatotoxicity: tiredness, nausea, vomiting, fever, rash, your skin or the white part of your eyes turns yellow (jaundice), or stomach pain/tenderness.
  • gallbladder problems. Gallbladder problems such as gallstones, or inflammation of the gallbladder, or inflammation of the pancreas from gallstones can occur with MASH and may occur if you take Rezdiffra. Call your healthcare provider right away if you develop any signs or symptoms of these conditions, including nausea, vomiting, fever, or pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen to your back and the pain may happen with or without vomiting.

The most common side effects of Rezdiffra include diarrhea, nausea, itching, stomach pain, vomiting, dizziness, and constipation.

These are not all the possible side effects of Rezdiffra. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1‑800‑FDA‑1088 or www.fda.gov/medwatch. You may also report side effects to Madrigal Pharmaceuticals, Inc. at 1‑800‑905‑0324.

What is Rezdiffra?

Rezdiffra is a prescribed medicine used along with diet and exercise to treat adults with metabolic dysfunction–associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver.

This indication is approved based on improvement of MASH and liver scarring (fibrosis). There are ongoing studies to confirm the clinical benefit of Rezdiffra.

Please see the full Prescribing Information, including Patient Information, for Rezdiffra.

Important Safety Information and Indication

Before you take Rezdiffra, tell your healthcare provider about all of your medical conditions, including if you:

  • have any liver problems other than MASH.
  • have gallbladder problems or have been told you have gallbladder problems, including gallstones.
  • are pregnant or plan to become pregnant. It is not known if Rezdiffra will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if Rezdiffra passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take Rezdiffra.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

  • Rezdiffra and other medicines may affect each other, causing side effects. Rezdiffra may affect the way other medicines work, and other medicines may affect how Rezdiffra works.
  • Especially tell your healthcare provider if you take medicines that contain gemfibrozil to help lower your triglycerides, or cyclosporine to suppress your immune system, because Rezdiffra is not recommended in patients taking these medicines.
  • Tell your healthcare provider if you are taking medicines such as clopidogrel to thin your blood or statin medicines to help lower your cholesterol.
  • Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

What are the possible side effects of Rezdiffra?

Rezdiffra may cause serious side effects, including:

  • liver injury (hepatotoxicity). Stop taking Rezdiffra and call your healthcare provider right away if you develop the following signs or symptoms of hepatotoxicity: tiredness, nausea, vomiting, fever, rash, your skin or the white part of your eyes turns yellow (jaundice), or stomach pain/tenderness.
  • gallbladder problems. Gallbladder problems such as gallstones, or inflammation of the gallbladder, or inflammation of the pancreas from gallstones can occur with MASH and may occur if you take Rezdiffra. Call your healthcare provider right away if you develop any signs or symptoms of these conditions, including nausea, vomiting, fever, or pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen to your back and the pain may happen with or without vomiting.

The most common side effects of Rezdiffra include diarrhea, nausea, itching, stomach pain, vomiting, dizziness, and constipation.

These are not all the possible side effects of Rezdiffra. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1‑800‑FDA‑1088 or www.fda.gov/medwatch. You may also report side effects to Madrigal Pharmaceuticals, Inc. at 1‑800‑905‑0324.

What is Rezdiffra?

Rezdiffra is a prescribed medicine used along with diet and exercise to treat adults with metabolic dysfunction–associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver.

This indication is approved based on improvement of MASH and liver scarring (fibrosis). There are ongoing studies to confirm the clinical benefit of Rezdiffra.

Please see the full Prescribing Information, including Patient Information, for Rezdiffra.